| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |